Quick Read
- Tulane clinched a spot in the 2025 College Football Playoff as the fifth highest-ranked conference champion.
- Tulane will face Texas Tech in the first round of the CFP; winner advances to play Georgia.
- Immunologist Elizabeth B. Norton at Tulane received a $1.6 million Gates Foundation grant to develop a novel oral polio vaccine.
- The new vaccine uses a unique adjuvant system to improve safety and accessibility in low-resource settings.
- CDC reported over 650 polio cases worldwide from January 2023 to June 2024, highlighting ongoing need for better vaccines.
Tulane’s Playoff Dream Becomes Reality
As the 2025 college football season barrels toward its dramatic close, Tulane University finds itself in the rare position of making headlines both on and off the field. In the world of college athletics, Tulane’s football team has clinched a coveted spot in the College Football Playoff (CFP) as the fifth highest-ranked conference champion, according to NCAA.com’s latest bracket projection based on the committee’s November rankings. For a program that has often had to fight for recognition, this achievement marks a significant milestone.
How did Tulane get here? The American Athletic Conference proved fiercely competitive, with Tulane, North Texas, Navy, South Florida, and East Carolina all vying for the championship game. According to ESPN, Tulane secured its berth either by winning its crucial final matchup or, in certain tie scenarios, by holding the highest composite computer average among 6-2 teams. Ultimately, Tulane’s resilience throughout the season paid off, as it finished 9-2 and earned the automatic playoff bid reserved for the top conference champions.
For Tulane fans, the anticipation is electric. The first round of the CFP places Tulane on the road against No. 5 Texas Tech, with the winner advancing to face No. 4 Georgia in the quarterfinals. It’s a daunting path, but one that signals Tulane’s arrival on college football’s biggest stage. The playoff schedule, set for December 19-20, includes campus-hosted first-round games before shifting to historic venues like the Cotton Bowl, Orange Bowl, Rose Bowl, and Sugar Bowl for the quarterfinals. Should Tulane pull off a string of upsets, the team could find itself vying for a national championship in Miami come January 19.
Inside the Numbers: Tulane’s Road to the Playoff
Looking closer at the mechanics, Tulane’s playoff spot is more than a matter of wins and losses. The selection process combines conference records, head-to-head results, and advanced metrics — specifically, composite computer rankings that evaluate team performance across dozens of statistical categories. This system rewards consistency and quality wins, giving programs like Tulane a fighting chance even against traditionally dominant teams.
The 2025 CFP bracket, as presented by NCAA.com, highlights the parity and unpredictability of this year’s competition. Tulane’s 9-2 record stacks up against Texas Tech’s 10-1, underscoring the challenge ahead. The expanded playoff format, which now includes automatic bids for the five highest-ranked conference champions, has opened doors for programs outside the perennial powerhouses. For Tulane, this means a chance not just to compete, but to redefine its legacy.
Scientific Breakthrough: $1.6 Million Grant for Polio Vaccine Research
Off the gridiron, Tulane’s impact is just as profound. In November, Tulane University immunologist Elizabeth B. Norton, PhD, was awarded a $1.6 million grant from the Gates Foundation to develop a next-generation oral polio vaccine, as reported by news.tulane.edu. Norton’s research, conducted in partnership with Q-Vant Biosciences and global health nonprofit PATH, aims to create a vaccine that is safe, effective, and easily administered — particularly vital for under-resourced communities still vulnerable to polio outbreaks.
The innovative vaccine uses a unique combination adjuvant, blending a soapbark tree-derived material with a modified bacterial protein. This approach is designed to guide vaccine components through gut tissue and trigger a robust immune response, but with non-live antigens that reduce the risk of reversion associated with existing oral polio vaccines. Norton’s goal is ambitious: to produce a vaccine that not only protects individuals but also curtails community transmission, moving the world closer to total polio eradication.
Why does this matter now? Despite global efforts, polio persists, with the Centers for Disease Control confirming over 650 cases in 39 countries between January 2023 and June 2024. The need for accessible, sustainable vaccines remains urgent, especially in regions with limited healthcare infrastructure. Norton’s project explores alternative delivery methods, such as liquid or fast-dissolving tablets, which could revolutionize vaccination campaigns in low-resource settings.
Tulane’s Broader Impact: Beyond Sports and Science
What’s striking about Tulane’s 2025 story is its duality — a university excelling in both high-stakes athletics and world-changing research. The playoff berth brings national attention, energizing alumni and students alike. At the same time, the polio vaccine grant underscores Tulane’s commitment to global health and social responsibility. The university’s ability to compete at the highest athletic levels while driving scientific innovation is a testament to its evolving identity in the 21st century.
For the Tulane community, these achievements serve as powerful reminders that success isn’t one-dimensional. On the football field, the Green Wave has earned its place among the nation’s elite. In the laboratory, Tulane researchers are working to eradicate diseases that still threaten millions worldwide. The university’s story this year is not just about trophies or grants — it’s about the intersection of ambition, resilience, and impact.
Tulane’s 2025 highlights reveal a university at its most dynamic: forging new paths in college sports while tackling urgent global health challenges. The convergence of these successes reflects a culture where striving for excellence is the norm, not the exception, and where every win — whether on the field or in the lab — matters.

